REGISTERED NUMBER: 04725520 (England and Wales)

WESSEX PHARMACY LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr H Popat

Mr B L Popat

Mrs A Popat

SECRETARY:

Mr B L Popat

REGISTERED OFFICE:

114 Wessex Way

Cox Green

Maidenhead

Berkshire

SL6 3DL

REGISTERED NUMBER:

04725520 (England and Wales)

ACCOUNTANTS:

Benifacts Accountants Ltd

Chartered Certified Accountants

Ashley House

97 London Road

Langley

Slough

Berkshire

SL3 7RS

BANKERS:

HSBC Plc

128 High Street

SLough

Berkshire

SL1 1JF

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

374,243

370,745

374,243

370,745

CURRENT ASSETS

Stocks

40,000

49,150

Debtors

6

245,778

287,009

Cash at bank and in hand

291,994

158,915

577,772

495,074

CREDITORS

Amounts falling due within one year

7

323,517

331,340

NET CURRENT ASSETS

254,255

163,734

TOTAL ASSETS LESS CURRENT LIABILITIES

628,498

534,479

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

628,398

534,379

SHAREHOLDERS' FUNDS

628,498

534,479

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 November 2025 and were signed on its behalf by:

Mr H Popat - Director

1.	STATUTORY INFORMATION

Wessex Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2003, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on cost and 25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 30 (2024 - 28 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2024

and 31 March 2025

640,000

AMORTISATION

At 1 April 2024

and 31 March 2025

640,000

NET BOOK VALUE

At 31 March 2025

-

At 31 March 2024

-

5.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

£

£

COST

At 1 April 2024

344,518

152,513

497,031

Additions

-

12,492

12,492

At 31 March 2025

344,518

165,005

509,523

DEPRECIATION

At 1 April 2024

-

126,286

126,286

Charge for year

-

8,994

8,994

At 31 March 2025

-

135,280

135,280

NET BOOK VALUE

At 31 March 2025

344,518

29,725

374,243

At 31 March 2024

344,518

26,227

370,745

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

173,041

160,196

Other debtors

72,737

126,813

245,778

287,009

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

2,261

2,515

Hire purchase contracts

-

7,584

Trade creditors

236,085

244,468

Taxation and social security

81,533

72,484

Other creditors

3,638

4,289

323,517

331,340

8.	SECURED DEBTS

The following secured debts are included within creditors:

2025

2024

£

£

The bank loans are secured by a charge over the assets of the company.